Abstract Details

Title Phase I Analysis of Systemic Interferon Alpha Utilized with Gliadel in Subjects with Recurrent Glioblastoma Multiforme (GBM)

Topic Neuro-oncology

Presentation(s) (-)

Poster/Presentation
Number 009

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Surasak Phuphanich, MD, FAAN (SURASAK PHUPHANICH MD)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Irene Malaty, MD, FAAN (University of Florida)	Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.

��ɫ��